PlainPharmaWatch

CMS Open Payments · Tool

BioFire Diagnostics, LLC vs Array Biopharma Inc

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

BioFire Diagnostics, LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 3,299, versus 112 for the other company. Its single largest recorded recipient represents 0.5% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

BioFire Diagnostics, LLC
HHI 3,299 · top recipient 0.5%
Ranked #532 of 1,838 companies by HHI
Array Biopharma Inc
HHI 112 · top recipient 0.0%
Ranked #1,674 of 1,838 companies by HHI

Payment Overview

Total Payments
$3.1M
% of Industry
0.0%
Transactions
300
Avg per Transaction
$10.2K
Recipients
11
Avg per Recipient
$278.8K
Payment Types
2
Top Payment Type
Consulting Fee
Total Payments
$3.1M
% of Industry
0.0%
Transactions
8,783
Avg per Transaction
$350.56
Recipients
8,513
Avg per Recipient
$361.68
Payment Types
4
Top Payment Type
Compensation for Services Other Than Consulting

Highlighted values indicate the higher figure for each metric.

Total payments compared

BioFire Diagnostics, LLC vs Array Biopharma Inc - total reported payments in CMS Open Payments PY2024

Array Biopharma Inc$3.1MBioFire Diagnostics, LLC$3.1M

Payment Types Breakdown

BioFire Diagnostics, LLC

Consulting Fee $2.0K

0.1%

Food and Beverage $564.95

0.0%

Array Biopharma Inc

Compensation for Services Other Than Consulting $228.5K

7.4%

Food and Beverage $159.8K

5.2%

Travel and Lodging $9.9K

0.3%

Consulting Fee $2.0K

0.1%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

BioFire Diagnostics, LLC

  1. 1

    CHRISTINA MUZNY

    $1,180.00 · 2 txns

  2. 2

    JEFFREY KLAUSNER

    $850.00 · 1 txns

  3. 3

    LARISSA MAY

    $300.25 · 2 txns

  4. 4

    KEVIN MESSACAR

    $105.42 · 1 txns

  5. 5

    FERRIC FANG

    $49.00 · 1 txns

Array Biopharma Inc

  1. 1

    SARMEN SARKISSIAN

    $17,956.78 · 11 txns

  2. 2

    SAJEVE THOMAS

    $15,365.67 · 6 txns

  3. 3

    Emory University Hospital

    $14,000.00 · 3 txns

  4. 4

    MAEN ABDELRAHIM

    $12,112.02 · 5 txns

  5. 5

    UNIVERSITY HOSPITAL

    $11,500.00 · 3 txns

Summary Comparison

Metric BioFire Diagnostics, LLC Array Biopharma Inc
Total Payments $3.1M $3.1M
% of Industry Total 0.0% 0.0%
Transaction Count 300 8,783
Avg per Transaction $10.2K $350.56
Recipient Count 11 8,513
Avg per Recipient $278.8K $361.68
Payment Type Count 2 4
Top Payment Type Consulting Fee Compensation for Services Other Than Consulting

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.